Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9624227 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases

Patent 9624227 was granted and assigned to Medimmune Limited on April, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 22, 2014
0
Date of Patent
April 18, 2017
0
Patent Application Number
14579094
0
Patent Citations Received
‌
US Patent 11771775 Pyrrolobenzodiazepine-antibody conjugates
‌
US Patent 12121590 Pyrrolobenzodiazepines and conjugates thereof
0
‌
US Patent 11938192 Dosage regimes for the administration of an anti-CD19 ADC
0
‌
US Patent 11701430 Pyrrolobenzodiazepines and conjugates thereof
0
‌
US Patent 11702473 Site-specific antibody-drug conjugates
0
Patent Inventor Names
Luke Masterson
0
Philip Wilson Howard
0
Stephen John Gregson
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9624227
0
Patent Primary Examiner
‌
Sun Jae Yoo
0

Find more entities like US Patent 9624227 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.